Novel calibration design improves knowledge transfer across products for the characterization of pharmaceutical bioprocesses.

Journal: Biotechnology journal
PMID:

Abstract

Modern machine learning has the potential to fundamentally change the way bioprocesses are developed. In particular, horizontal knowledge transfer methods, which seek to exploit data from historical processes to facilitate process development for a new product, provide an opportunity to rethink current workflows. In this work, we first assess the potential of two knowledge transfer approaches, meta learning and one-hot encoding, in combination with Gaussian process (GP) models. We compare their performance with GPs trained only on data of the new process, that is, local models. Using simulated mammalian cell culture data, we observe that both knowledge transfer approaches exhibit test set errors that are approximately halved compared to those of the local models when two, four, or eight experiments of the new product are used for training. Subsequently, we address the question whether experiments for a new product could be designed more effectively by exploiting existing knowledge. In particular, we suggest to specifically design a few runs for the novel product to calibrate knowledge transfer models, a task that we coin calibration design. We propose a customized objective function to identify a set of calibration design runs, which exploits differences in the process evolution of historical products. In two simulated case studies, we observed that training with calibration designs yields similar test set errors compared to common design of experiments approaches. However, the former requires approximately four times fewer experiments. Overall, the results suggest that process development could be significantly streamlined when systematically carrying knowledge from one product to the next.

Authors

  • Laura M Helleckes
    Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany.
  • Claus Wirnsperger
    DataHow AG, Zurich, Switzerland.
  • Jakub Polak
    DataHow AG, Zurich, Switzerland.
  • Gonzalo Guillén-Gosálbez
    Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland.
  • Alessandro Butté
    DataHow AG, Zurich 8093, Switzerland.
  • Moritz von Stosch
    Technical Research and Development, GSK, 89 Rue De L'Institut, B-1330 Rixensart, Belgium; Current affiliation: Data How AG, Zürichstrasse 137, 8600 Dübendorf, Switzerland.